rs199472947
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000238.4(KCNH2):c.1853C>T(p.Thr618Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.1853C>T | p.Thr618Ile | missense_variant | Exon 7 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Long QT syndrome Pathogenic:1
This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 618 of the KCNH2 protein (p.Thr618Ile). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with short QT syndrome (PMID: 21130771; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 67297). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects KCNH2 function (PMID: 21130771, 23300672, 23471968). For these reasons, this variant has been classified as Pathogenic. -
Cardiovascular phenotype Pathogenic:1
The p.T618I pathogenic mutation (also known as c.1853C>T), located in coding exon 7 of the KCNH2 gene, results from a C to T substitution at nucleotide position 1853. The threonine at codon 618 is replaced by isoleucine, an amino acid with similar properties. This alteration has been reported in multiple cases of short QT syndrome (SQTS) and has segregated with SQTS in multiple families, many of which had significant histories of arrhythmia and sudden death (Sun Y et al. J Mol Cell Cardiol. 2011;50:433-41; Mazzanti A et al. J Am Coll Cardiol. 2014;63:1300-8; Giustetto C et al. HeartRhythm Case Rep. 2015;1:373-378; Harrell DT et al. Int. J Cardiol. 2015;190:393-402; Hu D et al. JACC Clinical Electrophysiology. 2017;3(7)727-743). In addition, in vitro functional studies have reported this alteration to result in altered channel function, suggesting a gain of function effect (Lees-Miller JP et al. Biophys J. 2009;96:3600-10; Sun Y et al. J Mol Cell Cardiol. 2011;50:433-41; El Harchi A et al. PLoS ONE. 2012;7:e52451; Hu D et al. JACC Clinical Electrophysiology. 2017;3(7)727-743). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Short QT syndrome Other:1
This variant has been reported as associated with Short QT syndrome in the following publications (PMID:21130771). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at